EBS R&D to Revenue
Emergent Biosolutions Inc · R&D to Revenue
EBS R&D to Revenue
Latest reported7.24%period ending
EBS FY R&D/Revenue (425.96% → 7.24%)
Latest values, visible window
High-resolution chart · PNG
EBS r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 7.2419% | |
| 6.7746% | |
| 10.6166% | |
| 16.8501% | |
| 13.2612% | |
| 15.0827% | |
| 20.4521% | |
| 18.2515% | |
| 17.3649% | |
| 21.8699% | |
| 24.3569% | |
| 25.8912% | |
| 38.3485% | |
| 46.0559% | |
| 45.6618% | |
| 31.2034% | |
| 31.7685% | |
| 33.3065% | |
| 29.4989% | |
| 29.7914% | |
| 14.0648% | |
| 12.117% | |
| 0% | |
| 3.5752% | |
| 425.9639% |